(Q38152735)

29 August 2017

title

Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review (English)

1 reference

29 August 2017

A M Robert

1

1 reference

29 August 2017

L Robert

series ordinal

2

1 reference

29 August 2017

publication date

15 October 2013

1 reference

Pathology and Oncology Research

29 August 2017

published in

1 reference

29 August 2017

volume

20

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

1-10

1 reference

Antioxidants, oxidative damage and oxygen deprivation stress: a review

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Role of xanthine oxidoreductase as an antimicrobial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Organic compound synthesis on the primitive earth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Purinergic signaling during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

The chemistry of xanthine oxidase. The problems of enzyme inactivation and stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Pathophysiology of ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Structure and function of xanthine oxidoreductase: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Consequences of impaired purine recycling in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Attenuated variants of Lesch-Nyhan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrate reduction: evaluation of its role in nitrite and nitric oxide generation in anoxic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Hypercholesterolemia increases endothelial superoxide anion production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Latest evidence on gout management: what the clinician needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Reduction of reperfusion injury of human myocardium by allopurinol: A clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Does superoxide underlie the pathogenesis of hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Uric acid: A marker of increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Gout and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Long-term cardiovascular mortality among middle-aged men with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Gout, allopurinol use, and heart failure outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Allopurinol as a cardiovascular drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

A Crystalline Material with Xanthine Oxidase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

Anti-Tumour and Biochemical Effects of Purified Bovine Xanthine Oxidase in C3H and C Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9698-X

[New method of extraction and purification of xanthine dehydrogenase from milk.]

21 January 2018

1 reference

12 December 2020

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

1 reference

12 December 2020

Studies on milk fat globule membranes

1 reference

12 December 2020

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

12 December 2020

Studies on metalloflavoproteins. I. Xanthine oxidase, a molybdoflavoprotein

1 reference

12 December 2020

Action of high pressures on xanthine oxidase from milk

1 reference

12 December 2020

[Anti-oxidants, controversies and perspectives: how can the failure of clinical studies using anti-oxidants be explained?]

1 reference

12 December 2020

[Action of ultrasounds on xanthine oxidase from milk]

1 reference

12 December 2020

Xanthine oxidase and neutrophil infiltration in intestinal ischemia

1 reference

12 December 2020

[Kinetics of the detection of xanthine dehydrogenase in cow's milk.]

1 reference

12 December 2020

Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury

1 reference

12 December 2020

New data on the detection of xanthine dehydrogenase of milk by chemical agents

1 reference

12 December 2020

The Milk fat globule membrane

1 reference

12 December 2020

Uric acid and cardiovascular risk

1 reference

12 December 2020

Enzymopathic gout. Dyspurinia due to hypoxanthine-guanine-phosphoribosyl-transferase deficiency. Occurrence and clinical characteristics of enzyme repression

1 reference

12 December 2020

NADH oxidase activity of human xanthine oxidoreductase--generation of superoxide anion

1 reference

12 December 2020

Purification and partial characterization of xanthine oxidase from human milk

1 reference

12 December 2020

Superoxide radicals in feline intestinal ischemia

1 reference

12 December 2020

Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia

1 reference

12 December 2020

10.1007/S12253-013-9698-X

Identifiers

DOI

1 reference

29 August 2017

1 reference